Targeted Antimicrobial Agents as Potential Tools for Modulating the Gut Microbiome

被引:11
|
作者
Chou, Shuli [1 ]
Zhang, Shiqing [1 ]
Guo, Huating [1 ]
Chang, Yung-fu [2 ]
Zhao, Wenjing [1 ]
Mou, Xiangyu [1 ,3 ]
机构
[1] Shenzhen Campus Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen, Peoples R China
[2] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY USA
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Dis, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; polyphenols; bacteriocins; antimicrobial peptides; phage therapy; targeted drug delivery system; pathobionts; microbiome editing; FUSOBACTERIUM-NUCLEATUM; ANTI-MRSA; BACTERIOCIN; PEPTIDE; ASSOCIATIONS; MECHANISM; DATABASE; PLANT; PH;
D O I
10.3389/fmicb.2022.879207
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The gut microbiome plays a pivotal role in maintaining the health of the hosts; however, there is accumulating evidence that certain bacteria in the host, termed pathobionts, play roles in the progression of diseases. Although antibiotics can be used to eradicate unwanted bacteria, the side effects of antibiotic treatment lead to a great need for more targeted antimicrobial agents as tools to modulate the microbiome more precisely. Herein, we reviewed narrow-spectrum antibiotics naturally made by plants and microorganisms, followed by more targeted antibiotic agents including synthetic peptides, phage, and targeted drug delivery systems, from the perspective of using them as potential tools for modulating the gut microbiome for favorable effects on the health of the host. Given the emerging discoveries on pathobionts and the increasing knowledge on targeted antimicrobial agents reviewed in this article, we anticipate targeted antimicrobial agents will emerge as a new generation of a drug to treat microbiome-involved diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
    Zhu, Wen
    Dykstra, Kiersten
    Zhang, Lili
    Xia, Zongqi
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2021, 23 (11)
  • [42] Gut microbiome and NAFLD: impact and therapeutic potential
    Li, Liwei
    Cai, Fuqing
    Guo, Chen
    Liu, Zheng
    Qin, Jiamin
    Huang, Jiean
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [43] The Potential Impact of Probiotics on the Gut Microbiome of Athletes
    Wosinska, Laura
    Cotter, Paul D.
    O'Sullivan, Orla
    Guinane, Caitriona
    NUTRIENTS, 2019, 11 (10)
  • [44] The potential roles of gut microbiome in anal fistula
    Cai, Ping
    Rong, Hao
    Zhu, Qiaoqiao
    Dai, Xiaoyu
    Zhao, Jianpei
    AMB EXPRESS, 2023, 13 (01)
  • [45] The potential of nanoencapsulated probiotics in the modulation of the gut microbiome
    Pandey, Ramendra Pati
    Dhiman, Ruby
    Chang, Chung-Ming
    NANOMEDICINE, 2025, 20 (04) : 335 - 338
  • [46] The role of the Mediterranean diet in modulating the gut microbiome: A review of current evidence
    Gundogdu, Aycan
    Nalbantoglu, Ozkan Ufuk
    NUTRITION, 2023, 114
  • [47] The potential roles of gut microbiome in anal fistula
    Ping Cai
    Hao Rong
    Qiaoqiao Zhu
    Xiaoyu Dai
    Jianpei Zhao
    AMB Express, 13
  • [48] Untapped potential of gut microbiome for hypertension management
    Gao, Kan
    Wang, Pu Xiu
    Mei, Xue
    Yang, Tao
    Yu, Kai
    GUT MICROBES, 2024, 16 (01)
  • [49] Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
    Lee, Yonghyun
    Kamada, Nobuhiko
    Moon, James J.
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 179
  • [50] Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease risk
    Liuzzo, Giovanna
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2021, 42 (22) : 2152 - 2153